Conference with accompanying exhibition
Technologies for Immuno-Oncology                                                                                             
     
     

Wednesday, April 3, 2019
           


9:30 - 18:00

Venue:
TranslaTUM - Center for Translational Cancer Research, Einsteinstraße 25, 81675 Munich 

The event is presented in cooperation with TranslaTUM – Center for Translational Cancer Research, and BioM Biotech Cluster Development GmbH.

Registration: Please register via our Online-Shop. 

Participation Fee: Members of Forum MedTech Pharma e.V.: 160 €, Non-members Research & Clinics: 240 €,
Non-members Industry 320 €  
(plus VAT 7%)

Concept and Organisation: Forum MedTech Pharma e.V.

Contact Person: Dr. Monika Mügschl-Scharf (muegschl@medtech-pharma.de)

Cancellations received before March 27, 2019 are exempt from charges. For later cancellations and for non-attendance, the full amount will be incurred. Your address data is only used internally by Forum MedTech Pharma e.V.



Topic

Immunotherapies against cancer open up completely new opportunities to fight this emperor of all maladies“. But for this kind of therapies to become widely applied and successful, technological hurdles have yet to be overcome.

For one, meaningful biomarkers must be identified, for patient stratification as well as for monitoring therapeutic success. On the other hand, some immuno-therapeutics are not the usual kind of drugs. They are so-called Advanced Therapy Medicinal Products (ATMPs), and their production, quality & security control and delivery to the patient are especially challenging.

At the Conference Technologies for Immuno-Oncology“, researchers, clinicians and companies will show approaches to tackle those challenges. The importance of translational research in unleashing the potential of those novel strategies to fight cancer will be highlighted.
There will be sessions on the following topics:
Biomarkers for Immuno-Oncology
Cell Engineering & Production 
Realisation of Therapies

In the afternoon of the conference day, attendees will have the opportunity to visit the research facilities at the TranslaTUM - Center for Translational Cancer Research. Company demonstrators as well as an accompanying exhibition will showcase technological innovations for immuno-oncology.

The complete programme will be published here by end of February. 

Images: fotolia/DesignCells, fotolia/sommart, TranslaTUM

Cookies erleichtern die Bereitstellung unserer Dienste. Mit der Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies verwenden.
Datenschutzerklärung
OK